Pure Global

SEIMITSU Direct Bilirubin - Indonesia BPOM Medical Device Registration

SEIMITSU Direct Bilirubin is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101422105. The device is manufactured by ONE CO.,LTD from Japan, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. SEIMITSU DIAGNOSTICS.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
SEIMITSU Direct Bilirubin
Analysis ID: AKL 20101422105

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

ONE CO.,LTD

Country of Origin

Japan

Authorized Representative

PT. SEIMITSU DIAGNOSTICS

AR Address

Harton Tower 7th Floor, Jl. Boulevard Artha Gading, Kel. Kelapa Gading Barat, Kec. Kelapa Gading, Jakarta Utara.

Registration Date

Oct 21, 2024

Expiry Date

Oct 20, 2027

Product Type

Clinical Chemistry Test System

Bilirubin (total or direct) test system (kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing